We are live on ! Find out more
EPIX

ESSA Pharma
EPIX

Delisted

EPIX was delisted on the 8th of October, 2025.

Back to rankings

8 hedge funds and large institutions have $11.5M invested in ESSA Pharma in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

0.16% less ownership

Funds ownership: 66.34% → 66.18% (-0.16%)

11% less funds holding

Funds holding: 9 → 8 (-1)

21% less capital invested

Capital invested by funds: $14.5M → $11.5M (-$3.01M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.18%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
–
Increased
4
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$80.2K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$873
3
TRCT
Tower Research Capital (TRC)
New York
+$669
4
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$147

Top Sellers

Rank Fund Capital Flow
1
DS
DRW Securities
Illinois
-$128K
2
EAM
Eventide Asset Management
Massachusetts
-$3

EPIX Hedge Fund Activity: Q3 2018 in Review

8 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in ESSA Pharma (EPIX) for Q3 2018, worth a combined $11.5M — down 21% from $14.5M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of EPIX and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 4 added.

The largest buyer was BVF Inc, adding an estimated $80.2K. The largest seller was DRW Securities, exiting entirely with an estimated $128K sold.

  • 8 institutional investors held ESSA Pharma (EPIX) as of Q3 2018, down from 9 in Q2 2018.
  • Funds reported $11.5M of ESSA Pharma stock for Q3 2018, down 21% quarter-over-quarter.
  • 0 funds opened new ESSA Pharma positions in Q3 2018 and 1 closed out, a net change of -1 holder.
  • The largest ESSA Pharma buyer in Q3 2018 was BVF Inc, an estimated $80.2K added.
  • The largest ESSA Pharma seller in Q3 2018 was DRW Securities, an estimated $128K sold.

Based on aggregated 13F filings for Q3 2018.